HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aihua Zhang Selected Research

CGK 733

7/2021Role of inhibiting Chk1-p53 pathway in hepatotoxicity caused by chronic arsenic exposure from coal-burning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aihua Zhang Research Topics

Disease

35Inflammation (Inflammations)
12/2021 - 12/2013
30Neoplasms (Cancer)
01/2022 - 05/2006
29Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 05/2011
21Fibrosis (Cirrhosis)
12/2021 - 07/2012
19Acute Kidney Injury (Acute Renal Failure)
01/2022 - 12/2015
14Chronic Renal Insufficiency
01/2022 - 01/2014
14Kidney Diseases (Kidney Disease)
11/2020 - 01/2014
12Carcinogenesis
12/2021 - 01/2014
10Arsenic Poisoning
12/2022 - 02/2002
10Ureteral Obstruction
11/2021 - 01/2014
10Proteinuria
01/2021 - 06/2011
10Albuminuria
11/2018 - 04/2014
8Hypertension (High Blood Pressure)
01/2021 - 11/2006
7Hypoxia (Hypoxemia)
01/2022 - 01/2016
6Liver Diseases (Liver Disease)
03/2021 - 08/2012
6Diabetic Nephropathies (Diabetic Nephropathy)
10/2020 - 01/2014
5Infections
01/2021 - 04/2005
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 02/2013
5Insulin Resistance
01/2021 - 10/2012
4Anemia
01/2022 - 01/2018
4Jaundice (Icterus)
01/2022 - 06/2012
4Ischemia
12/2021 - 05/2018
4Body Weight (Weight, Body)
03/2021 - 06/2005
4Atherosclerosis
01/2021 - 01/2016
4Skin Neoplasms (Skin Cancer)
05/2020 - 06/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 02/2013
4Liver Neoplasms (Liver Cancer)
04/2018 - 03/2013
4Neoplasm Metastasis (Metastasis)
01/2018 - 01/2016
4Wounds and Injuries (Trauma)
01/2018 - 01/2015
4Type 2 Diabetes Mellitus (MODY)
11/2017 - 04/2014
4Prostatic Neoplasms (Prostate Cancer)
09/2017 - 02/2003
3Necrosis
10/2022 - 01/2019
3Lung Injury
06/2022 - 11/2020
3Bartter Syndrome (Syndrome, Bartter)
02/2022 - 10/2018
3Lung Neoplasms (Lung Cancer)
12/2021 - 01/2016
3Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 01/2021
3Dental Fluorosis
09/2021 - 12/2017
3Sclerosis
01/2021 - 12/2013
3Alzheimer Disease (Alzheimer's Disease)
04/2017 - 03/2016
3Cognitive Dysfunction
01/2017 - 03/2016
3Nephrotic Syndrome (Syndrome, Nephrotic)
01/2017 - 01/2013
3Myocardial Ischemia (Ischemic Heart Diseases)
02/2016 - 02/2013
3Sleep Initiation and Maintenance Disorders (Insomnia)
02/2012 - 01/2012

Drug/Important Bio-Agent (IBA)

26ArsenicIBA
12/2022 - 02/2002
21Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2002
18Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2002
17arseniteIBA
10/2021 - 06/2014
14Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2016
11MicroRNAs (MicroRNA)IBA
01/2021 - 09/2015
10Pharmaceutical PreparationsIBA
10/2021 - 02/2012
10Coal (Coals)IBA
09/2021 - 02/2002
10AldosteroneIBA
07/2021 - 05/2011
9Dinoprostone (PGE2)FDA Link
11/2018 - 01/2013
8Therapeutic UsesIBA
02/2022 - 11/2010
8RotenoneIBA
12/2019 - 01/2014
7EnzymesIBA
01/2022 - 05/2006
7InflammasomesIBA
07/2021 - 09/2014
6CreatinineIBA
01/2022 - 10/2012
5manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA
01/2022 - 04/2015
5CytokinesIBA
10/2021 - 07/2010
5AntioxidantsIBA
03/2021 - 05/2006
5AlbuminsIBA
01/2019 - 04/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 06/2011
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2016 - 07/2012
4Messenger RNA (mRNA)IBA
12/2022 - 01/2016
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2015
4Adenosine Triphosphate (ATP)IBA
01/2022 - 06/2014
4roxadustatIBA
01/2022 - 01/2018
4CollagenIBA
12/2021 - 05/2018
4FluoridesIBA
09/2021 - 12/2017
4celastrolIBA
02/2021 - 01/2018
4LipidsIBA
02/2021 - 11/2017
4Biological ProductsIBA
01/2021 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2007
4SodiumIBA
01/2018 - 11/2006
4CarcinogensIBA
01/2018 - 04/2007
4Transcription Factors (Transcription Factor)IBA
01/2018 - 02/2003
4NPHS2 proteinIBA
01/2017 - 01/2012
4nephrinIBA
01/2017 - 01/2012
4SaltsIBA
01/2016 - 11/2006
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2015
3Coloring Agents (Dyes)IBA
10/2021 - 10/2019
3SeleniumIBA
03/2021 - 12/2014
3superoxide dismutase 2IBA
01/2021 - 01/2018
3Caspase 3 (Caspase-3)IBA
01/2021 - 07/2019
3Mitochondrial DNA (mtDNA)IBA
01/2021 - 06/2014
3Angiotensin IIIBA
01/2021 - 01/2016
3Long Noncoding RNAIBA
01/2021 - 01/2016
3ProstaglandinsIBA
05/2018 - 10/2016
3Interleukin-18 (Interleukin 18)IBA
01/2018 - 12/2015
3Circular RNAIBA
01/2018 - 01/2018
3Small Interfering RNA (siRNA)IBA
01/2017 - 01/2016
3yinchenhaoIBA
11/2016 - 06/2012
2Interleukin-17 (Interleukin 17)IBA
12/2022 - 01/2021

Therapy/Procedure

16Therapeutics
10/2021 - 04/2007
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 11/2010
4Renal Dialysis (Hemodialysis)
11/2022 - 01/2020
3Nephrectomy
01/2021 - 01/2016
3Ligation
01/2021 - 01/2018
3Drug Therapy (Chemotherapy)
01/2021 - 10/2012